AAVIN Capital III, LP has invested in Formulation Technology, Inc., enhancing its position in the growing nutritional supplement industry.
Target Information
AAVIN Capital III, LP has successfully completed an investment to facilitate the acquisition of Formulation Technology, Inc. (commonly referred to as FormTech). Founded in 1982, FormTech is a prominent contract manufacturer specializing in vitamins and dietary supplements. The company provides a comprehensive range of services including product development, manufacturing, packaging, and labeling for various forms of nutritional products such as tablets, capsules, powders, and chewable supplements.
FormTech operates from a state-of-the-art 40,000-square-foot facility that complies with the stringent regulations set by the Food and Drug Administration (FDA) for dietary supplements, over-the-counter products, and prescription drugs, as well as the corresponding requirements in Canada. This adherence to regulatory standards underscores FormTech's commitment to quality and safety in the nutritional industry.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The nutritional supplement market has experienced significant growth in recent years, driven by increasing consumer interest in health and wellness. In the United States, the indust
Similar Deals
Premium Brands Holdings Corporation → Stampede Culinary Partners, Inc.
2026
HALO Dream Inc. → Baby Merlin
2025
Altas Partners → Redwood Services
2025
Crown Laboratories, Inc. → Revance Therapeutics, Inc.
2025
Entrepreneurial Equity Partners → Bil-Jac Foods
2025
AAVIN Capital III, LP
invested in
Formulation Technology, Inc.
in 2025
in a Other Private Equity deal